Company

Dali Pharmaceutical Co. Ltd

Headquarters: Dali, China

Employees: 298

SSE: 603963 +2.01%

Market Cap

CN¥603.1 Million

CNY as of July 1, 2024

US$83.0 Million

Market Cap History

Dali Pharmaceutical Co. Ltd market capitalization over time

Evolution of Dali Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Dali Pharmaceutical Co. Ltd

Detailed Description

Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Dali Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603963 wb_incandescent

Details

Headquarters:

No. 118, West Huancheng Road

Xiaguan Town

Dali, 671000

China